Rapid Micro Biosystems(RPID)
$0.75-0.01 (-0.80%)
RPID
Rapid Micro Biosystems financials statements
$0.75
At close:-0.01 (-0.80%)
Want to see RPID full AI Analyst Report?
Rapid Micro Biosystems (RPID) Ratios
110 Followers
Rapid Micro Biosystems Ratios
RPID's free cash flow for Q2 2026 was $-12.48M. For the 2026 fiscal year, RPID's free cash flow was increased by $223.00K and operating cash flow was $-12.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.31 | 4.61 | 6.34 | 7.27 | 12.01 |
| Quick Ratio | 2.36 | 3.46 | 5.29 | 6.16 | 11.14 |
| Cash Ratio | 1.08 | 0.96 | 1.28 | 1.42 | 9.82 |
| Solvency Ratio | -1.05 | -1.91 | -1.94 | -2.19 | -3.57 |
| Operating Cash Flow Ratio | -1.68 | -2.51 | -2.37 | -3.07 | -3.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -36.37 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 19.52M | $ 58.10M | $ 94.95M | $ 112.09M | $ 197.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.06 | 0.05 | 0.04 | 0.00 |
| Debt-to-Equity Ratio | 0.72 | 0.08 | 0.06 | 0.05 | 0.00 |
| Debt-to-Capital Ratio | 0.42 | 0.08 | 0.06 | 0.05 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.25 | 1.30 | 1.22 | 1.16 | 1.09 |
| Debt Service Coverage Ratio | -39.25 | -35.85 | 0.00 | 0.00 | -17.28 |
| Interest Coverage Ratio | -43.48 | 0.00 | 0.00 | 0.00 | -17.82 |
| Debt to Market Cap | 0.15 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.56 | 0.14 | 0.17 | 0.19 | 0.06 |
| Net Debt to EBITDA | -0.09 | 0.25 | 0.32 | 0.32 | 3.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.65% | -0.39% | -24.36% | -49.85% | -33.32% |
| EBIT Margin | -136.94% | -167.08% | -251.18% | -368.99% | -203.31% |
| EBITDA Margin | -127.25% | -155.09% | -237.39% | -352.43% | -196.72% |
| Operating Profit Margin | -141.10% | -177.96% | -251.18% | -368.99% | -203.31% |
| Pretax Profit Margin | -140.18% | -167.08% | -232.85% | -358.27% | -316.09% |
| Net Profit Margin | -140.30% | -167.16% | -232.99% | -354.91% | -316.48% |
| Continuous Operations Profit Margin | -140.30% | -167.16% | -232.99% | -354.91% | -316.48% |
| Net Income Per EBT | 100.08% | 100.05% | 100.06% | 99.06% | 100.12% |
| EBT Per EBIT | 99.35% | 93.89% | 92.70% | 97.09% | 155.47% |
| Return on Assets (ROA) | -62.95% | -47.76% | -36.57% | -31.89% | -30.49% |
| Return on Equity (ROE) | -141.91% | -62.23% | -44.47% | -37.04% | -33.27% |
| Return on Capital Employed (ROCE) | -84.08% | -61.93% | -45.44% | -36.84% | -21.18% |
| Return on Invested Capital (ROIC) | -82.19% | -61.01% | -45.03% | -36.33% | -21.18% |
| Return on Tangible Assets | -62.95% | -47.76% | -36.57% | -31.89% | -30.49% |
| Earnings Yield | -36.37% | -119.56% | -164.79% | -126.75% | -16.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.25 | 3.73 | 4.03 | 3.13 | 4.13 |
| Payables Turnover | 6.28 | 11.11 | 14.19 | 4.73 | 7.85 |
| Inventory Turnover | 1.48 | 1.39 | 1.40 | 1.21 | 1.98 |
| Fixed Asset Turnover | 2.57 | 1.72 | 1.18 | 0.82 | 2.06 |
| Asset Turnover | 0.45 | 0.29 | 0.16 | 0.09 | 0.10 |
| Working Capital Turnover Ratio | 0.63 | 0.34 | 0.20 | 0.11 | 0.19 |
| Cash Conversion Cycle | 224.65 | 326.88 | 324.95 | 340.82 | 226.68 |
| Days of Sales Outstanding | 35.62 | 97.92 | 90.49 | 116.77 | 88.48 |
| Days of Inventory Outstanding | 247.18 | 261.83 | 260.17 | 301.22 | 184.67 |
| Days of Payables Outstanding | 58.15 | 32.86 | 25.72 | 77.17 | 46.48 |
| Operating Cycle | 282.80 | 359.74 | 350.66 | 417.99 | 273.16 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.70 | -1.01 | -1.05 | -1.38 | -1.33 |
| Free Cash Flow Per Share | -0.71 | -1.04 | -1.09 | -1.54 | -1.40 |
| Dividend Paid and CapEx Coverage Ratio | -36.54 | -32.35 | -24.43 | -8.69 | -17.09 |
| Capital Expenditure Coverage Ratio | -36.54 | -32.35 | -24.43 | -8.69 | -17.09 |
| Operating Cash Flow Coverage Ratio | -1.30 | -7.16 | -6.14 | -7.35 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.92 | -1.57 | -2.00 | -3.42 | -2.37 |
| Free Cash Flow Yield | -24.63% | -116.06% | -147.39% | -136.09% | -13.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.76 | -0.83 | -0.61 | -0.79 | -6.00 |
| Price-to-Sales (P/S) Ratio | 3.86 | 1.40 | 1.41 | 2.80 | 18.99 |
| Price-to-Book (P/B) Ratio | 3.90 | 0.52 | 0.27 | 0.29 | 2.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.06 | -0.86 | -0.68 | -0.73 | -7.58 |
| Price-to-Operating Cash Flow Ratio | -4.17 | -0.89 | -0.71 | -0.82 | -8.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.99 | 0.07 | 0.04 | 0.03 | -0.10 |
| Enterprise Value Multiple | -3.12 | -0.65 | -0.28 | -0.48 | -5.75 |
| Enterprise Value | 133.41M | 28.48M | 14.90M | 28.88M | 262.83M |
| EV to EBITDA | -3.12 | -0.65 | -0.28 | -0.48 | -5.75 |
| EV to Sales | 3.97 | 1.02 | 0.66 | 1.69 | 11.31 |
| EV to Free Cash Flow | -4.18 | -0.63 | -0.32 | -0.44 | -4.52 |
| EV to Operating Cash Flow | -4.30 | -0.64 | -0.33 | -0.49 | -4.78 |
| Tangible Book Value Per Share | 0.74 | 1.73 | 2.74 | 3.87 | 5.33 |
| Shareholders’ Equity Per Share | 0.74 | 1.73 | 2.74 | 3.87 | 5.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.01 | -0.00 |
| Revenue Per Share | 0.75 | 0.64 | 0.52 | 0.40 | 0.56 |
| Net Income Per Share | -1.05 | -1.08 | -1.22 | -1.43 | -1.77 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 0.93 | 0.97 | 1.55 |
| Research & Development to Revenue | 0.41 | 0.52 | 0.57 | 0.75 | 0.42 |
| SG&A to Revenue | 1.04 | 1.26 | 1.11 | 1.57 | 0.77 |
| Stock-Based Compensation to Revenue | 0.12 | 0.14 | 0.21 | 0.23 | 0.08 |
| Income Quality | 0.66 | 0.94 | 0.86 | 0.96 | 0.75 |
Currency in USD
